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Abstract
Background: Efficient, accurate instruments for measuring depression are increasingly important
in clinical practice. We developed a computerized adaptive version of the Beck Depression
Inventory (BDI). We examined its efficiency and its usefulness in identifying Major Depressive
Episodes (MDE) and in measuring depression severity.
Methods: Subjects were 744 participants in research studies in which each subject completed both
the BDI and the SCID. In addition, 285 patients completed the Hamilton Depression Rating Scale.
Results: The adaptive BDI had an AUC as an indicator of a SCID diagnosis of MDE of 88%,
equivalent to the full BDI. The adaptive BDI asked fewer questions than the full BDI (5.6 versus 21
items). The adaptive latent depression score correlated r = .92 with the BDI total score and the
latent depression score correlated more highly with the Hamilton (r = .74) than the BDI total score
did (r = .70).
Conclusions: Adaptive testing for depression may provide greatly increased efficiency without
loss of accuracy in identifying MDE or in measuring depression severity.
Background
There is a pressing need for accurate and efficient instru-
ments to screen for depression and to measure its severity,
for several reasons. First, the U.S. Preventive Services Task
Force [1] recommended adults be screened for depres-
sion, based on findings that feedback of depression
screening to clinicians increased the recognition of
depressive illness. Moreover, a great proportion of depres-
sion care is in the hands of clinicians who lack specialized
mental health training [2,3]. These clinicians may benefit
from methods to detect cases and evaluate the outcomes
of care. For example, it has been recognized for some time
that depression is an important source of morbidity in pri-
mary care [4], and that improvement is needed in the rec-
ognition and management of depression in that setting
[5,6]. However, clinician time and attention are highly
constrained in many health care settings [7].
Published: 06 May 2004
BMC Psychiatry 2004, 4:13
Received: 23 December 2003
Accepted: 06 May 2004
This article is available from: http://www.biomedcentral.com/1471-244X/4/13
© 2004 Gardner et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.BMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/13
Page 2 of 11
(page number not for citation purposes)
Second, efficient yet accurate instruments to measure
depression would also be of considerable value in moni-
toring the progress of treatment by mental health special-
ists and other treating clinicians. Systematic case
management activities involving regular outcome meas-
urement are part of an emerging paradigm of high quality
care of chronic illnesses [8-11]. However, such programs
will fail if patients are unwilling to adhere to measure-
ment protocols. Therefore, follow-up measurement pro-
tocols cannot burden patients with repeated exposures to
long questionnaires. Finally, researchers frequently assess
severity of depression using standard instruments such as
the Beck Depression Inventory (BDI) [12]. Efficiency is
important here as well, because researchers often assess
many constructs, straining study participants' endurance.
Given that many instruments permit assignments of diag-
noses, measurement of symptoms, or assessment of func-
tioning, one might ask why routine depression screening
and treatment monitoring are not already common.
Although these instruments are commonly used in
research, they have had less effect on clinical care. One
important reason is that the time and other costs of men-
tal health assessments may outweigh their benefits for
busy patient-care settings. These costs may also make
screening or treatment monitoring suboptimal from a
societal perspective. For example, a recent simulation
study by Valenstein and her colleagues [13] suggested that
screening for depression would not meet a reasonable cri-
terion for cost-utility if the cost of administering a single
test was substantially higher than $5, where that cost com-
prised a fee for the instrument, six minutes of staff time,
and one minute of physician time.
Computerized adaptive measurement of depression
Two technical advances could substantially improve the
tradeoff between efficiency and accuracy in the measure-
ment of mental health problems, such as depression. First,
the Internet is reducing the cost and other barriers to the
delivery of computerized testing services to clinical
offices. Wireless Internet connectivity is becoming widely
available, and powerful, mobile tablet and handheld
computers are now available at commodity prices. These
technologies should substantially reduce the cost of
putting computer-administered tests in the hands of
patients and clinicians in front-line clinical settings. Com-
puterized tests, particularly those that can be self-admin-
istered by patients, can reduce the staff and clinician time
required to administer and score an instrument. There are
several computerized mental health instruments includ-
ing, for example, a computerized version of the Compos-
ite International Diagnostic Interview (CIDI) [14,15].
The second technical advance, Computerized Adaptive
Testing (CAT) [16], has been widely used by educational
and vocational testers, but has seen surprisingly little
application in physical or mental health settings [17,18].
CAT is a technology for interactive administration of tests
that tailors the test to the examinee (or, in our application,
to the patient). These tests are 'adaptive' in the sense that
the testing is driven by an algorithm that selects questions
in real time and in response to the ongoing responses of
the patient. We believe that computerized, adaptive men-
tal health assessment services, delivered on stand-alone
computers or over the web, could make significant contri-
butions to both mental health research and clinical care.
In this article, we discuss how CAT can be used to screen
for, and measure severity of, depression.
The need to achieve both accuracy and efficiency poses a
difficult tradeoff for an instrument developer, for two rea-
sons. First, classical test theory [19] teaches that, every-
thing else being equal, the way to make a test more
accurate is to increase its length, so that random errors in
the responses to individual items cancel each other out.
Second, the need to accurately measure patients with var-
ying levels of severity of disorder lengthens tests. Failing to
include items about symptoms reflecting a wide range of
severity of disorder will result in an instrument with a
floor or ceiling effect [17]. Thus, an accurate and wide-
ranging instrument should include several questions at
each relevant level of severity of disorder.
Unfortunately, a fixed instrument that has multiple ques-
tions for each of several ranges of severity is an inefficient
instrument for any individual patient. That individual
patient has a disorder the severity of which falls into only
one of those ranges, and questions that ask about much
more or much less severe symptoms are often irrelevant to
that patient. In summary, until recently the goals of hav-
ing a brief, efficient instrument and an accurate, wide-
ranging instrument have seemed mutually incompatible.
Computerized adaptive testing
CAT can improve the terms on which accuracy and effi-
ciency are traded off. It has two components. First, one
administers the instrument via computer, using a device
such as a touch screen, or through a computer-adminis-
tered telephone interview [20,21]. Research on computer-
ized tests [22] has shown that the medium has few
negative effects on how subjects respond. To the contrary,
computerized data collection directly from patients
appears to reduce social desirability bias in the reporting
of alcohol and drug use, sexual activity, and medication
noncompliance [23]. Of particular interest, is the sugges-
tion that people seem to prefer revealing some types of
very personal information e.g., gynecological details [24],
sexual abuse [25], or suicidal ideation [26] to a computer
than a person. Similarly, alcoholics seeking treatmentBMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/13
Page 3 of 11
(page number not for citation purposes)
disclosed greater levels of consumption of alcohol to a
computer than to a person [27].
CAT, however, goes farther. 'Adaptive' means that the
computer follows an algorithm that administers a test (for
example, the BDI) to a patient one question at a time. At
each step, the patient's prior responses determine (a)
whether to ask another question and (b) which question
to ask [16,28]. The test stops when the patient's score has
been estimated to a prescribed level of precision. Hence,
the computer adapts the test to use the fewest items
required to assess that particular patient accurately. By com-
parison, an instrument using a fixed list of items may have
too few items to accurately measure some patients, while
posing unnecessary questions to others.
To that end, at each step, the program uses the current
subset of responses to estimate the patient's score on a
latent trait, in this case depression, as well as a confidence
interval (CI) around that estimate [29]. The latent trait is
conventionally denoted as θ, and is conventionally
expressed in standardized units. However, θ could be
rescaled to the same units as the BDI to aid clinicians
familiar with that instrument. The CI around θ is then
compared to the 'cut' or criterion score on the latent trait
that defines a positive screening result. If the upper bound
of the CI were to fall below the cut score, the program
would declare the screening result negative, and stop test-
ing. Conversely, if the lower bound of the CI were to fall
above the cut score, testing would stop with a positive
result. Otherwise, the CI includes the cut score, and testing
continues.
Suppose now that we are in mid-test, and the adaptive
algorithm has to choose another question to pose to a
respondent. Using the data already collected about the
respondent, the program calculates an information statis-
tic for each of the test items that have not yet been posed.
The information statistic for an item is larger if the
response to that item is expected to make a greater reduc-
tion in our uncertainty about the patient's true score on
the latent depression dimension. The computer then
presents the maximally informative item to the respond-
ent. Everything else being equal, a question will be more
informative if the severity of the symptoms it concerns is
similar to our current estimate of the severity of the
patient's depression. For example, if we already have sub-
stantial evidence of depression based on the responses
thus far, the computer will discount the value of items that
primarily ask about minor symptoms, and focus on those
that ask about severe symptoms. Please notice that the
adaptive algorithm we describe here is different from the
branching logic used in many computerized tests to skip
questions based on earlier patient responses. Programs
that use branching identify questions to be skipped
because those questions are irrelevant based on a patient's
previous answers. Adaptive tests choose questions to be
asked because those questions maximize the precision of
the patient's estimated score on a latent dimension of
interest.
We reasoned that adaptive technology could substantially
improve the efficiency of psychometric measurement in
clinical settings, with little or no cost in the accuracy of
measurement. We sought to test this by developing an
adaptive version of the BDI. We chose the BDI because it
is a well-validated instrument for depression and repre-
sentative of the many screening instruments available for
this common condition. It is brief, has been very widely
used, and is already in a self-report format.
The goals of this study were (a) to test whether an adaptive
version of the BDI would predict a Structured Clinical
Interview for DSM-IV Axis I Disorders (SCID) [30] diag-
nosis as accurately as the full BDI, (b) to estimate how
many fewer questions the adaptive BDI would ask, and (c)
to determine whether the adaptive BDI would measure
the severity of depression as well as the full BDI. The sta-
tistical methodology underlying adaptive testing is well
established and there is considerable experience in using
it in other domains of measurement [16,31]. In a previous
study [32], we showed that the screening decisions made
by an adaptive version of the Pediatric Symptom Checklist
(PSC) [33] agreed nearly perfectly with the screening deci-
sions made by the full PSC (κ = .97). The adaptive PSC
achieved that agreement by asking an average of only 10.5
questions per patient, compared to the 35 items required
by the full PSC. However, that study did not examine
whether adaptive testing affected the PSC's accuracy,
which would have required comparing screening deci-
sions based on adaptive data to independent psychomet-
ric criteria. To our knowledge, there have been no studies
of how an adaptive implementation of a screen for mental
health problems affects the agreement between the screen
and criterion measures. In this study, we evaluated the
performance of an adaptive version of the BDI against an
independent SCID diagnosis and Hamilton depression
measure.
Methods
Study group and data
This study combined data from nine projects at the Uni-
versity of Pittsburgh. We looked for recent studies in
which subjects had both a BDI and a SCID. 1) Two-hun-
dred and nineteen assessments were obtained from moth-
ers seeking treatment for their children in a rural mental
clinic from 1998 to 2000. 2) Seventeen depressed women
were recruited from a rural mental center in Western
Pennsylvania in 1999 for a pilot psychotherapy protocol.
3) Twenty-three subjects participated in a pilot study ofBMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/13
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cognitive behavioral treatment for traumatic grief in 1999
and 2000. 4) Forty-three women came from a descriptive
study of anger in pregnant or post-partum women [34]
who presented for treatment of mood and anxiety disor-
ders in a psychiatric clinic in a university medical center in
1996 and 1997. 5) Eighty-seven subjects came from a
study of maintenance therapy in bipolar disorder. 6) Nine
subjects came from a study of borderline personality dis-
order. 7) Fourteen subjects came from a pilot study of
brief interpersonal psychotherapy. 8) One hundred
eighty-three subjects came from a study of maintenance
psychotherapy in women with recurrent major depres-
sion. 9) Finally, 149 subjects came from a study of normal
sleeping patterns in adults. These latter subjects were
selected based on having no lifetime history of mental dis-
orders as measured by the SADS or the SCID, as well as no
first-degree family history of mental disorders.
For 285 of these patients, we also had Hamilton Depres-
sion Rating Scale [35] scores obtained within one week of
the BDIs to serve as an independent measure of the sever-
ity of depression. For this subset, we were able to compare
whether the Adaptive BDI correlated with the Hamilton as
well as the total score of the full BDI.
Pooling these data sets resulted in 744 subjects. Of these,
84% were female, 91% were European-Americans, and
the average age was 37 (SD = 8.6 years). All subjects in
these studies had completed a BDI and had received a
diagnostic evaluation with the SCID. Patients completed
the BDI before treatment, during a symptomatic period at
or near the time of the diagnostic interview. Three hun-
dred thirty-nine participants had either a SCID diagnosis
of major depressive disorder, or bipolar disorder in which
it could be established through independent and concur-
rent assessments that the patient had completed the BDI
in a depressed phase. These unipolar and bipolar depres-
sives were classified as having an MDE. Of the remaining
405 participants, 256 had diagnoses other than MDE, and
149 had no diagnosed disorders.
Beck Depression Inventory (BDI)
The BDI is a widely used 21-item depression survey (there
is an additional skip-out item that was ignored in this
analysis). Each item on the BDI includes four response
statements describing increasing severity of depression. A
few (<0.2%) scores on specific BDI questions were miss-
ing. Randomly imputed scores replaced these values.
Item Response Theory (IRT) modeling
IRT [36-38] has replaced classical test theory [19] as the
leading psychometric theory for surveys and tests in edu-
cation, the social sciences, and increasingly, for patient-
reported data in health care [17,18,32]. In a test created
using classical test theory, there are points assigned to
each response to each question (for example, 1 point for
a 'yes' response to a yes/no question about a depression
symptom and 0 points for a 'no' response). You would
score the test by summing the points to compute a total
score. You would interpret the result by locating that total
score to the distribution of total scores in a normative
sample, perhaps judging the result problematic if the total
score fell in the upper 10% of a national sample of
respondents. IRT is based on a mathematical model that,
for each item on a test, regresses the person's response to
the item on a latent score that represents the attribute of
the person that the instrument measures. The person's
score on the test is estimate of the value of the latent vari-
able that maximizes the likelihood of the person's pattern
of responses. In the proposed research, the latent dimen-
sion of interest might be viewed as the severity of the
patient's substance use. To model the BDI, we used the
graded-response model [36], a variant of IRT for polyto-
mous data.
Adaptive testing simulation
The goal of this study was to determine how well the
adaptive BDI predicted SCID diagnoses of MDE, how well
it measured depression severity, and how efficient it was
compared to the regular BDI. To simulate the adaptive use
of the BDI, we wrote a program that interacted with the
Adaptive BDI. This program simulated a patient taking the
test by using participants' paper and pencil BDI data as if
they had been collected adaptively. For each participant,
the simulation began by asking the question that was
most informative based on the assumption that the partic-
ipant's latent depression score was the population mean;
this is the BDI's question 7, which concerns the subject's
disappointment with self. However, we knew how each
participant had responded to question 7 on the paper and
pencil BDI, and we assumed that he or she would have
made the same response if the question had been asked
through an adaptive process. Taking the participant's
actual response to question 7 as the response to the first
question in the simulated adaptive testing session, the
computer used the adaptive algorithm to choose the next
question. Similarly, at each subsequent step we used the
participants' actual responses to drive the algorithm
forward.
Next, we used the simulated patient program to measure
how well the Adaptive BDI would predict MDE and the
BDI total score, using the strategy of internal cross-valida-
tion [39]. In this strategy, we first partitioned the 744 cases
into 100 groups of seven or eight participants. We then
held out the cases in the first of the hundred groups and
estimated the IRT model underlying the adaptive BDI
using the remaining 99% of the data. The parameter esti-
mates from the IRT model were then substituted into the
program implementing the Adaptive BDI. The patientBMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/13
Page 5 of 11
(page number not for citation purposes)
simulation program then used the 1% of participants
whose data had not been used in the IRT estimation in a
simulation of the adaptive use of the BDI. We then
repeated this procedure for each of the other 1% sub-
groups of participants, until all 744 participants had
served as 'fresh' cases in the simulations of the adaptive
use of the BDI.
To compute an ROC curve for the adaptive BDI, we eval-
uated how the adaptive BDI would behave at each of 30
evenly spaced cut points on θ (the latent depression
score), ranging from -4.0 to 4.0 (θ has mean 0 and stand-
ard deviation 1). Through simulation, for each cut point
we determined how many questions the algorithm would
ask for each participant, and what screening decision it
would make when it stopped. Thus, it was possible to
compute the sensitivity and specificity of the adaptive BDI
for each θ cut point, and therefore to calculate its ROC
curve and the AUC.
To measure the efficiency of the adaptive BDI, we calcu-
lated the average number of questions asked by the adap-
tive algorithm at a cutpoint that offered high levels of
both sensitivity and specificity. To assess how well it func-
tioned as a measure of depression severity, we calculated
the correlation between the adaptive BDI and the Hamil-
ton scale.
Simulating variance in the prevalence of MDE
An important problem in our study was that we used
research samples, in which the prevalence of MDE was
higher than would be found in many clinical settings. To
address this, we compared the adaptive BDI and the regu-
lar BDI in several bootstrapping analyses [40] in which we
oversampled cases that did not have a diagnosis of MDE.
Results
IRT analysis of the BDI
The transformation of an existing instrument into an
adaptive test begins with a psychometric analysis of the
instrument, based on Item Response Theory (IRT)
[18,36,41,42]. To this end, we first performed a factor
analysis of the BDI data to assess the dimensionality of the
instrument. Unidimensionality of the factor structure of
the test items – which means that the associations among
patients' responses to the BDI items can be accounted for
by a single factor – is an important assumption underlying
unidimensional IRT and CAT [36]. We used a factor anal-
ysis model appropriate for ordinal categorical data [43],
and estimated it using the program Mplus [44].
In our factor analysis, the first factor accounted for 58% of
the variance in the BDI (eigenvalue = 12.2), while the next
factor accounted for 6% (eigenvalue = 1.2). Fitting a one-
factor model to the data produced a root mean-square
residual statistic of .048. This statistic ranges between 0
and 1, with small values reflecting a better fit; .05 is often
used as a criterion for adequacy of fit. We concluded that
a unidimensional model fit the data adequately, as did
Clark and his colleagues [45]. Other authors have fit more
than one correlated factor to different sets of BDI data [46-
48]. Differing results in factor analyses often reflect differ-
ences in sample selection. Our study involved a mixture of
patients and healthy participants and it is likely that there
was greater variance in the severity of depression among
these patients than in studies including primarily psychi-
atric cases or primarily healthy participants such as college
students. If so, we would expect to find a large first factor
measuring severity of depression that accounted for a high
proportion of the variance in BDI responses. Having
established that a unidimensional solution fit the data,
the IRT modeling was performed using the program
PARSCALE [49,50].
ROC analysis of the Adaptive BDI
The baseline for evaluating the accuracy of the adaptive
BDI was the accuracy of the 21-item BDI, so we began by
computing the Area Under the Curve (AUC) of the ROC
curve [51] for the BDI total score (  = 16.3, SD = 12.8),
when the latter was used as an indicator of a SCID diagno-
sis of MDE. The ROC curve for the 21-item BDI total score
had an AUC = 89.4% (95% confidence interval = [87.1%,
91.7%]). The ROC curve for the adaptive BDI (Figure 1)
was almost identical, with AUC = 88.4%. Note that this
statistic and all the following results are cross-validated
estimates.
We then examined the ROC curve for the adaptive BDI
and chose the point that offered the best combination of
high sensitivity and high specificity (sensitivity = 87.6%,
specificity = 79.3%, positive predictive value = 78.0%,
negative predictive value = 88.4%; cases were judged to be
positive if θ ≥ .135; this point is labeled 'Best Case' in Fig-
ure 1). Table 1 presents the agreement between the adap-
tive BDI and the SCID for this case. Figure 2 presents the
distributions of estimated θ scores, depending on whether
the patient had no diagnoses, a depression diagnosis
other than MDE, or MDE. The Kappa [52] for BDI-SCID
concordance was .66, which is considered a good level of
agreement by conventional standards. The average
number of questions asked was 5.6 (SD = 6.6), and for
69% of the subjects the algorithm asked fewer than five
questions (Figure 3). In addition, the algorithm asked
more questions about cases in which it decided that the
participant had an MDE (  = 6.3, SD = 7.2) than in cases
in which it decided that an MDE was not present (  =
4.9, SD = 5.8; Levene's t(725) = 2.83, p < .005).
Finally, we asked whether the adaptive BDI would be as
useful as the full BDI as a measure of the severity of
X
X
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depression. The estimated latent depression scores ( ) in
the 'best case' simulation were highly correlated (r = .92,
N = 744) with the BDI total score. For the 285 clinical
cases for whom we had both a BDI and a Hamilton score,
ROC curve for Adaptive BDI as an indicator of Major Depressive Disorder Figure 1
ROC curve for Adaptive BDI as an indicator of Major Depressive Disorder
Table 1: Cross-validated agreement between adaptive BDI 'best case' and SCID Major Depressive Episode: Unweighted results
SCID
Adaptive BDI Negative Positive Total
Negative 321 42 363
Positive 84 297 381
Total 405 339 744
ˆ θBMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/13
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the BDI total score had a correlation of r = .70 with the
Hamilton, while the correlation between   and the Ham-
ilton was r = .74. This difference is statistically significant
[p < .006, [53]].
The effect of prevalence of MDE
Our study group included more positive cases than a sam-
ple that might be found in medical settings other than
specialty mental health settings. To examine whether our
results would still hold if the prevalence of MDE were
lower, we conducted additional simulations in which we
created new study groups of cases by randomly sampling
cases with replacement from our data (i.e.,
bootstrapping). We generated 1000 bootstrap samples in
which the sampling weights on cases were set such that
the average prevalence of MDE in the bootstrap samples
was 10%. We then repeated our AUC analyses in each
bootstrapped sample. The results suggested that both the
regular BDI and adaptive BDI performed as well or better
when the prevalence of MDE was lower. That is, the aver-
age AUC for the agreements between the adaptive BDI and
the SCID was 92.4%, and the average AUC for the agree-
ments between the regular BDI and the SCID was 92.3%.
Box plot of distribution of Θ by depression diagnosis Figure 2
Box plot of distribution of Θ by depression diagnosis
341 186 217 N =
Diagnoses
Major depression Other depression Healthy
E
s
t
i
m
a
t
e
d
 
T
h
e
t
a
3
2
1
0
-1
-2
-3
ˆ θBMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/13
Page 8 of 11
(page number not for citation purposes)
Discussion
The AUC for the adaptive BDI was a respectable 88%,
indicating that the adaptive test could correctly classify
large proportions of both positive and negative cases. The
'best case' adaptive BDI was able to classify a subject using
an average of only 5.6 questions. The latent depression
score generated in that simulation was highly correlated
with the BDI total score. In addition, for the subset of the
data for which Hamilton scores were available, the latent
score was more highly correlated with the Hamilton than
the BDI total score was. The latter results indicate that the
adaptive BDI would be as useful as the full BDI as a meas-
ure of the severity of depression. Thus, in our simulation
the adaptive BDI was as accurate as the full scale BDI while
dramatically improving efficiency. We note that the CAT
algorithm can be 'tuned' to the assessment purpose at
hand, for which one might choose another point that
emphasized either sensitivity or specificity.
The results also suggested, however, that five or six ques-
tions would be the required number of items for only a
few participants. Indeed, the adaptive BDI asked fewer
than five questions for the majority of patients. Even
when the adaptive BDI asked few questions, it usually
made the same screening decision as the full BDI: the rates
of disagreements between the adaptive BDI and the SCID
Histogram of questions asked in 'best case' simulation Questions Figure 3
Histogram of questions asked in 'best case' simulation Questions
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were slightly higher when more questions were asked. In
addition, the algorithm asked more questions about pos-
itive cases. This is an attractive outcome, because the
patients' answers provide useful symptom data for the cli-
nician. Thus, an adaptive test budgets the patient and cli-
nician time spent on measuring depression, allocating it
primarily to persons for whom there are reasons for
concern.
A reduction of 15 questions may not seem important,
given that the full BDI takes only a few minutes to com-
plete. In our experience, however, clinicians are very con-
cerned about both office visit time and maintaining a
smooth flow of patients through the waiting room. In
addition, health care providers are confronted with rec-
ommendations that they screen for many illnesses and
health-related problems. Saving questions on a depres-
sion screen might free time to screen for other problems
such as domestic violence or substance abuse.
Based on this simulation, it appears that adaptive testing
has significant promise for settings where both high effi-
ciency and high accuracy are essential. These settings
include primary care, where clinician time is a rate-limit-
ing factor, and ongoing monitoring after successful
treatment in specialty mental health care, where respond-
ent burden is a constraint. The next step should be to field
test adaptive instruments and validate them prospectively,
to make certain that they are acceptable to patients and
clinicians, and to measure the costs of implementing
them.
Limitations
The principal limitation of our study is that it is a simula-
tion. In particular, we assumed that participants would
respond to questions presented adaptively similarly to the
way they responded on the paper BDI, and that the order
in which questions are asked does not have an important
effect on accuracy. We have some confidence in these
assumptions, based on prior research showing that adap-
tive versions of tests in other fields have accuracy that is
similar to paper and pencil versions [16].
A second limitation is that we compiled our study group
from several research studies. Although the study group
included a wide range of both healthy and acutely ill indi-
viduals, it would be preferable to have a random sample
from a defined health care setting. We attempted to statis-
tically control the prevalence of MDE in our bootstrap
analyses and found that the performance of the regular
and adaptive BDI improved slightly when the prevalence
of MDE was decreased. While this is reassuring, we specu-
late that because our study group may have lacked some
of the mildly depressed and difficult to classify cases that
are found in many real world settings. The sample that we
have collected may also explain why we found evidence
for only one factor in the BDI data, where other research-
ers have found evidence for two or more. Although we
view our study as providing strong support for the concept
of adaptive measurement of depression, because of these
limitations it needs to be replicated in an actual sample.
A final limitation of our study is the BDI itself. Our results
argue that a computerized adaptive test has the same sen-
sitivity and specificity as its full-length version, and the
same validity as a measure of symptom severity. Conver-
sion to CAT cannot, however, produce a test with higher
validity than the base instrument. Although the BDI is
widely used, one may still judge that, in light of a false
positive rate of 21%, neither the regular nor the adaptive
BDI is sufficiently accurate to serve as a screen for MDE.
Our results nevertheless suggest that whatever depression
instrument one chooses, it would be more efficient to
administer it adaptively.
Conclusions
We believe that adaptive testing could substantially
improve the tradeoff between accuracy and efficiency in
the assessment of psychopathology. The simulation con-
ducted here showed that the BDI, a widely used depres-
sion instrument, could be converted to a far more efficient
adaptive test without loss of accuracy. We need more stud-
ies to assess the performance of adaptive tests in both
mental health specialty and other clinical settings.
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